Giornale italiano di cardiologia最新文献_第6页

[The ETNA-AF Europe registry: 4-year data of edoxaban use in atrial fibrillation in the Italian real world compared to the European cohort]. [欧洲 ETNA-AF 登记：意大利心房颤动患者使用埃多沙班的 4 年数据与欧洲队列对比]。

IF 0.7

Giornale italiano di cardiologia Pub Date : 2024-11-01 DOI: 10.1714/0000.43289

Letizia Riva, Giuseppe Andò, Maurizio Anselmi, Roberto Cemin, Daniele Nassiacos, Giovanni Fionda, Raffaele De Caterina

{"title":"[The ETNA-AF Europe registry: 4-year data of edoxaban use in atrial fibrillation in the Italian real world compared to the European cohort].","authors":"Letizia Riva, Giuseppe Andò, Maurizio Anselmi, Roberto Cemin, Daniele Nassiacos, Giovanni Fionda, Raffaele De Caterina","doi":"10.1714/0000.43289","DOIUrl":"10.1714/0000.43289","url":null,"abstract":"Background: The prospective, single-arm, observational, phase 4 ETNA-AF Europe study collected real-world data about safety, effectiveness and therapeutic adherence in European patients with non-valvular atrial fibrillation newly prescribed with edoxaban and followed up for 4 years.Methods: Overall, 13 164 patients were included in the full-analysis set, which means that they had at least one documentation after baseline at 4 years. The current paper reports about the 3329 Italian patients out of the whole European population.Results: In the Italian cohort, median age was 76.0 (69.0-82.0) years, with 57.4% of the patients being ≥75 years old. The CHA2DS2-VASc score was >4 in 586 (18.1%) patients. At baseline, 670 (20.8%) patients were classified as frail by the investigators. Edoxaban 30 mg/day was prescribed to 1013 (31.8%) patients: these were older, with more comorbidities and a lower estimated creatinine clearance compared with those receiving 60 mg/day. All-cause mortality was 4.1%/year and there were very low yearly rates of bleeding and thromboembolic events: major bleeding, 0.9%; intracranial hemorrhage, 0.2%; ischemic stroke, 0.3%; systemic embolism, <0.1%. These events were more frequent in patients ≥75 years or in patients with renal impairment or treated with edoxaban 30 mg/day. Advancing age was not associated with an increased incidence of intracranial bleeding.Conclusions: These findings confirm the favorable long-term safety and effectiveness profile of edoxaban in non-valvular atrial fibrillation patients treated in routine clinical care in Italy.","PeriodicalId":12510,"journal":{"name":"Giornale italiano di cardiologia","volume":"25 11","pages":"819-832"},"PeriodicalIF":0.7,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142498438","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[2024 ESC Guidelines for the management of elevated blood pressure and hypertension]. [2024年ESC血压升高和高血压管理指南]。

IF 0.7

Giornale italiano di cardiologia Pub Date : 2024-11-01 DOI: 10.1714/4361.43518

John William McEvoy, Cian P McCarthy, Rosa Maria Bruno, Sofie Brouwers, Michelle D Canavan, Claudio Ceconi, Ruxandra Maria Christodorescu, Stella S Daskalopoulou, Charles J Ferro, Eva Gerdts, Henner Hanssen, Julie Harris, Lucas Lauder, Richard J McManus, Gerard J Molloy, Kazem Rahimi, Vera Regitz-Zagrosek, Gian Paolo Rossi, Else Charlotte Sandset, Bart Scheenaerts, Jan A Staessen, Izabella Uchmanowicz, Maurizio Volterrani, Rhian M Touyz

引用次数: 0

[Anomalous origin of left circumflex artery from the right sinus of Valsalva and left anterior descending artery with double intramyocardial tract: a rare case of angina]. [左侧环状动脉异常起源于右侧瓦尔萨尔瓦窦和左前降支动脉，伴有双心内膜束：一例罕见的心绞痛病例]。

IF 0.7

Giornale italiano di cardiologia Pub Date : 2024-11-01 DOI: 10.1714/4371.43688

Gerardo Musuraca, Cristiana Giovanelli, Clotilde Terraneo, Carlo Angheben, Nicola Osti, Emiliano Boldi, Nicola Martinelli

引用次数: 0

[Epidermal inclusion cyst mimicking an implantable cardiac defibrillator pocket infection: a rare finding]. [模仿植入式心脏除颤器袋感染的表皮包涵囊肿：一个罕见的发现]。

IF 0.7

Giornale italiano di cardiologia Pub Date : 2024-11-01 DOI: 10.1714/4352.43394

Stefano Maffè, Paola Paffoni, Luca Bergamasco, Marisa Arrondini, Eleonora Prenna, Emanuela Facchini, Stefano Ticozzi, Pierfranco Dellavesa

引用次数: 0

[Towards a standardized and minimalist future in interventional cardiology]. [实现介入心脏病学标准化和简约化的未来]。

IF 0.7

Giornale italiano di cardiologia Pub Date : 2024-11-01 DOI: 10.1714/4371.43682

Giulio Stefanini, Mauro Gitto

引用次数: 0

[The modified hugging balloon technique]. [改良拥抱气球技术]。

IF 0.7

Giornale italiano di cardiologia Pub Date : 2024-11-01 DOI: 10.1714/4371.43686

Claudio Moretti, Riccardo Mangione, Giacomo Giovanni Boccuzzi, Mario Iannaccone

{"title":"[The modified hugging balloon technique].","authors":"Claudio Moretti, Riccardo Mangione, Giacomo Giovanni Boccuzzi, Mario Iannaccone","doi":"10.1714/4371.43686","DOIUrl":"10.1714/4371.43686","url":null,"abstract":"Percutaneous coronary intervention has revolutionized the management of coronary artery disease, yet in-stent restenosis (ISR) remains a clinical challenge, especially when complicated by calcification. Various techniques are available for the modification of calcified ISR, including super-high-pressure balloon dilation, in-stent rotational atherectomy, excimer laser coronary atherectomy and intravascular lithotripsy (IVL). This case report presents a challenging scenario of very late calcified ISR in a large coronary artery, highlighting diagnostic and interventional considerations. A patient with a history of multiple cardiovascular risk factors presented with infero-lateral ST-elevation myocardial infarction. Coronary angiography revealed severe very late ISR in the distal right coronary artery. Despite initial interventions, severe stent under-expansion persisted due to extensive calcification. The operator employed shockwave lithotripsy alongside a non-compliant balloon to achieve the vessel diameter and an optimal stent expansion. While the evidence for some interventions is limited, case series and registries suggest promising outcomes with IVL, particularly in refractory cases. Our proposed approach addresses the limitations posed by vessel diameter, demonstrating potential efficacy in this challenging case. This case report emphasizes the need for tailored therapeutic strategies and the integration of innovative techniques in managing calcified ISR, with IVL emerging as a promising option in selected cases.","PeriodicalId":12510,"journal":{"name":"Giornale italiano di cardiologia","volume":"25 11","pages":"34S-36S"},"PeriodicalIF":0.7,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142715796","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Italian Society of Interventional Cardiology (SICI-GISE) Position paper: Integrated management and transcatheter interventions for acute pulmonary embolism]. [意大利介入心脏病学会（SICI-GISE）立场文件：急性肺栓塞的综合管理和经导管介入治疗]。

IF 0.7

Giornale italiano di cardiologia Pub Date : 2024-11-01 DOI: 10.1714/4371.43683

Chiara Fraccaro, Mario Iannaccone, Giacomo Giovanni Boccuzzi, Annalisa Boscolo Bozza, Gianpaolo Carrafiello, Andrea Dell'Amore, Luigi Di Serafino, Sofia Martin Suarez, Antonio Micari, Andrea Rolandi, Filippo Russo, Stefano Carugo, Antonio Di Lascio, Francesco Germinal, Simona Pierini, Alberto Menozzi, Massimo Fineschi, Tiziana Attisano, Marco Contarini, Carmine Musto, Federico De Marco, Alfredo Marchese, Giovanni Esposito, Giuseppe Tarantini, Francesco Saia

{"title":"[Italian Society of Interventional Cardiology (SICI-GISE) Position paper: Integrated management and transcatheter interventions for acute pulmonary embolism].","authors":"Chiara Fraccaro, Mario Iannaccone, Giacomo Giovanni Boccuzzi, Annalisa Boscolo Bozza, Gianpaolo Carrafiello, Andrea Dell'Amore, Luigi Di Serafino, Sofia Martin Suarez, Antonio Micari, Andrea Rolandi, Filippo Russo, Stefano Carugo, Antonio Di Lascio, Francesco Germinal, Simona Pierini, Alberto Menozzi, Massimo Fineschi, Tiziana Attisano, Marco Contarini, Carmine Musto, Federico De Marco, Alfredo Marchese, Giovanni Esposito, Giuseppe Tarantini, Francesco Saia","doi":"10.1714/4371.43683","DOIUrl":"10.1714/4371.43683","url":null,"abstract":"Pulmonary embolism (PE) is commonly treated primarily with pharmacological therapy, while advanced reperfusion therapies (transcatheter or surgical) are considered only in cases of contraindications or failure of standard therapies. Treatment algorithms vary depending on the patient's risk, with patients at intermediate or high risk potentially requiring evaluation for such advanced reperfusion therapies. Critical scenarios, such as contraindications to systemic thrombolysis or failure of pharmacological protocols, necessitate the activation of a multidisciplinary pulmonary embolism response team (PERT) and prompt therapeutic escalation. Integrated in-hospital pathways and the extension of PERT at the provincial/regional level are recommended to improve access to advanced therapies and promote uniform management of PE. Larger randomized clinical trials are needed to assess the efficacy of transcatheter therapies compared to current standards. In conclusion, a multidisciplinary and standardized approach, supported by evidence-based guidelines, is essential to optimize PE management and improve clinical outcomes. The Italian Society of Interventional Cardiology (SICI-GISE) aims to promote such standardization nationally with this expert position paper, ensuring appropriateness and equity of care for patients, as well as fostering further scientific research and education.","PeriodicalId":12510,"journal":{"name":"Giornale italiano di cardiologia","volume":"25 11","pages":"5S-23S"},"PeriodicalIF":0.7,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142715734","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[The development of a Hub & Spoke network for transcatheter aortic valve replacement procedures: the operational model of the Interventional Cardiology Unit at the IRCCS San Raffaele Hospital (OSR Hub-Spoke)]. [经导管主动脉瓣置换术枢纽和辐条网络的发展：IRCCS San Raffaele 医院介入心脏病科的运行模式（OSR Hub-Spoke）]。

IF 0.7

Giornale italiano di cardiologia Pub Date : 2024-11-01 DOI: 10.1714/4371.43684

Luca Angelo Ferri, Francesco Federico, Claudio Gentilini, Paolo Bonfanti, Giovanni Corrado, Alfredo Castelli, Mauro Carlino, Marco Ancona, Barbara Bellini, Filippo Russo, Ciro Vella, Domitilla Gentile, Giulia Ghizzoni, Alaide Chieffo, Matteo Montorfano

{"title":"[The development of a Hub & Spoke network for transcatheter aortic valve replacement procedures: the operational model of the Interventional Cardiology Unit at the IRCCS San Raffaele Hospital (OSR Hub-Spoke)].","authors":"Luca Angelo Ferri, Francesco Federico, Claudio Gentilini, Paolo Bonfanti, Giovanni Corrado, Alfredo Castelli, Mauro Carlino, Marco Ancona, Barbara Bellini, Filippo Russo, Ciro Vella, Domitilla Gentile, Giulia Ghizzoni, Alaide Chieffo, Matteo Montorfano","doi":"10.1714/4371.43684","DOIUrl":"10.1714/4371.43684","url":null,"abstract":"Recently, an increase in the number of patients with severe aortic stenosis eligible for transcatheter aortic valve implantation (TAVI) has been observed worldwide. In order to reduce waiting lists, provide to all patients referred to us equal access to care and to further improve the collaboration with spoke centers, we developed a specific Hub & Spoke specific protocol for TAVI. According to our protocol, a clinical selection (with echo and computed tomography scan) is done by Spoke centers, the case is discussed with a multidisciplinary team online and the procedure is planned (access, valve type size). At day 0, the patient is admitted in Spoke centers where blood samples are taken; at day 1, the patient is transferred to a Hub center for the TAVI procedure and after 2 h of observation, if no adverse events are registered, the patient is transferred back to the Spoke center. Since 2019, an agreement among our center and two hospitals has been signed. According to this Hub & Spoke model, a total of 72 patients with aortic stenosis were treated with TAVI (mean age 83 years, 48.6% female, median Society of Thoracic Surgeons risk 2.4 ± 1.1%, left ventricular ejection fraction 58.0 ± 7.75%). More frequently CoreValve Evolut R (47.2%) was used. Only 2 patients had a prolonged admission at Hub and were not transferred at day 1 (1 vascular complication and 1 intra-procedural resuscitated cardiac arrest). This Hub & Spoke model guaranteed shortening of waiting lists, more effective turnover of bed, equal access to care to patients referred to our center. In addition, it helped also to increase Awareness and education as well as appropriate training of the teams from spoke facilities.","PeriodicalId":12510,"journal":{"name":"Giornale italiano di cardiologia","volume":"25 11","pages":"24S-28S"},"PeriodicalIF":0.7,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142715789","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Diagnosis of arrhythmogenic cardiomyopathy: 20 years of progress and innovation]. [心律失常性心肌病的诊断：20 年的进步与创新]。

IF 0.7

Giornale italiano di cardiologia Pub Date : 2024-10-01 DOI: 10.1714/4336.43216

Domenico Corrado, Alessandro Zorzi, Barbara Bauce, Ilaria Rigato, Alberto Cipriani, Martina Perazzolo Marra, Kalliopi Pilichou, Cristina Basso, Simone Ungaro, Francesca Graziano

{"title":"[Diagnosis of arrhythmogenic cardiomyopathy: 20 years of progress and innovation].","authors":"Domenico Corrado, Alessandro Zorzi, Barbara Bauce, Ilaria Rigato, Alberto Cipriani, Martina Perazzolo Marra, Kalliopi Pilichou, Cristina Basso, Simone Ungaro, Francesca Graziano","doi":"10.1714/4336.43216","DOIUrl":"https://doi.org/10.1714/4336.43216","url":null,"abstract":"Arrhythmogenic cardiomyopathy (CMA) is a cardiac disease characterized by non-ischemic ventricular scarring and electrical instability. The diagnosis of CMA still remains challenging today and requires the use of a set of criteria, since no single diagnostic test represents the gold standard. The first diagnostic criteria were defined and disseminated in 1994 and then revised in 2010, focusing mainly on right ventricular involvement. In 2019, an international panel of experts identified the limitations of the previous diagnostic criteria. The 2020 Padua criteria included a specific pathway for the diagnosis of left ventricular variants and emphasized the need for the use of cardiac magnetic resonance imaging in the characterization of myocardial scarring. These criteria were further refined and published in 2023 as European Task Force (TF) criteria, thus gaining international recognition.Exploring the history of CMA and its diagnosis, in this review we analyze the changes and progress in the 20 years that have occurred from the first version of the criteria in 1994 to the latest in European TF of 2023, highlighting the evolution of our knowledge of the pathobiology and morpho-functional characteristics of the disease. One of the most relevant updates is undoubtedly the introduction of the concept of \"scarring/arrhythmogenic cardiomyopathy\", a definition that enhances the main features of the pathology and emphasizes the multiplicity of phenotypes and clinical presentations independent of etiology.","PeriodicalId":12510,"journal":{"name":"Giornale italiano di cardiologia","volume":"25 10","pages":"735-746"},"PeriodicalIF":0.7,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142344793","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Successful percutaneous treatment of complex heart disease in a stage IV non-small cell lung cancer survivor]. [成功经皮治疗一名 IV 期非小细胞肺癌幸存者的复杂心脏病]。

IF 0.7

Giornale italiano di cardiologia Pub Date : 2024-10-01 DOI: 10.1714/4336.43217

Davide Bosi, Pierluigi Demola, Giulia Alberti, Sergio Musto D'Amore, Mario Larocca, Vincenzo Guiducci, Carmine Pinto, Alessandro Navazio, Luigi Tarantini

{"title":"[Successful percutaneous treatment of complex heart disease in a stage IV non-small cell lung cancer survivor].","authors":"Davide Bosi, Pierluigi Demola, Giulia Alberti, Sergio Musto D'Amore, Mario Larocca, Vincenzo Guiducci, Carmine Pinto, Alessandro Navazio, Luigi Tarantini","doi":"10.1714/4336.43217","DOIUrl":"10.1714/4336.43217","url":null,"abstract":"The presence of metastatic cancer represents a high-risk condition for the treatment of heart disease requiring surgical or percutaneous procedures. We present the case of a 58-year-old man with pulmonary adenocarcinoma and renal metastases surviving more than 3 years after chemotherapy and immunotherapy suffering dyspnea and chest pain on minimal exertion due to 99% anterior coronary artery stenosis associated with severe aortic stenosis of a bicuspid valve. We treated the cardiac lesions in two steps by coronary angioplasty with drug-eluting stent implantation followed by percutaneous prosthetic aortic valve replacement. The procedures were successful with resolution of the symptoms and recovery of the usual ECOG-PS 0-1 functional capacity which persists 24 months after cardiac procedures. This case demonstrates that the multidisciplinary collaboration between oncologists and cardiologists with a personalized patient-centered approach allows to treat complex clinical situations successfully in the emerging category of patients surviving with metastatic cancer.","PeriodicalId":12510,"journal":{"name":"Giornale italiano di cardiologia","volume":"25 10","pages":"747-751"},"PeriodicalIF":0.7,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142344802","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0